Bioconstat (0827.810.866): financials and annual accounts

Bioconstat

Ghent ·KBO/BCE: BE 0827.810.866

Line	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Balance sheet: assets
`20/58`	208,744	241,054	227,395	254,414	285,920	291,994	285,796	333,372	389,692	287,963	296,679	325,094	101,513	83,524	52,854
`21/28`	185,929	200,077	214,491	228,330	264,848	280,599	275,933	290,784	318,624	221,560	198,204	194,716	5,802	5,268	670
`22/27`	185,929	200,077	214,491	228,330	264,848	280,599	275,933	289,984	317,824	221,560	198,204	194,716	5,802	5,268	670
`22`	183,079	197,227	211,376	224,868	261,040	276,528	270,642	283,472	314,712	215,619	188,781	180,751	-	-	-
`23`	-	-	-	-	-	-	-	-	262	523	785	693	1,386	2,078	-
`24`	-	0	266	612	958	1,221	2,441	3,662	-	2,567	5,788	10,423	1,567	340	670
`26`	2,850	2,850	2,850	2,850	2,850	2,850	2,850	2,850	2,850	2,850	2,850	2,850	2,850	2,850	-
`28`	-	-	-	-	-	-	-	800	800	-	-	-	-	-	-
`29/58`	22,816	40,977	12,904	26,083	21,072	11,395	9,863	42,589	71,068	66,404	98,475	130,378	95,711	78,256	52,184
`40/41`	18,710	40,000	5,828	10,507	14,142	9,339	9,652	38,102	66,216	62,869	89,209	100,072	82,236	56,633	45,830
`40`	18,710	40,000	4,556	9,554	12,883	6,549	6,246	35,362	66,195	51,094	77,434	84,144	76,736	56,633	45,830
`41`	-	0	1,272	953	1,259	2,790	3,406	2,741	21	11,775	11,775	15,929	5,500	-	-
`54/58`	0	3	6,900	15,455	6,810	2,056	211	2,287	4,033	3,535	9,266	30,306	13,475	21,622	6,355
`490/1`	4,105	974	176	122	120	-	-	2,199	819	-	-	-	-	-	-
Balance sheet: equity and liabilities
`10/49`	208,744	241,054	227,395	254,414	285,920	291,994	285,796	333,372	389,692	287,963	296,679	325,094	101,513	83,524	52,854
`10/15`	-125,415	-86,871	-98,137	-64,745	-37,003	-20,281	9,481	80,146	70,898	48,592	63,661	37,102	33,233	17,530	7,474
`10/11`	18,600	18,600	18,600	18,600	18,600	-	18,600	18,600	18,600	18,600	6,380	6,380	6,380	6,380	6,380
`100`	-	-	-	-	-	-	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600
`101`	-	-	-	-	-	-	-	-	-	-	12,220	12,220	12,220	12,220	12,220
`11`	-	-	-	-	-	18,600	-	-	-	-	-	-	-	-	-
`1100/10`	-	-	-	-	-	18,600	-	-	-	-	-	-	-	-	-
`13`	52,966	52,966	52,966	52,966	52,966	52,966	52,966	52,966	52,966	30,660	1,860	1,860	1,860	1,860	55
`130/1`	1,860	1,860	1,860	1,860	1,860	1,860	-	-	-	-	-	-	-	-	-
`130`	-	-	-	-	-	-	1,860	1,860	1,860	1,860	1,860	1,860	1,860	1,860	55
`1311`	1,860	1,860	1,860	1,860	-	-	-	-	-	-	-	-	-	-	-
`1319`	-	-	-	-	1,860	1,860	-	-	-	-	-	-	-	-	-
`133`	51,106	51,106	51,106	51,106	51,106	51,106	51,106	51,106	51,106	28,800	-	-	-	-	-
`14`	-196,981	-158,436	-169,703	-136,311	-108,568	-91,846	-62,084	8,580	-668	-668	55,421	28,862	24,993	9,290	1,039
`17/49`	334,160	327,924	325,533	319,159	322,923	312,274	276,315	253,227	318,795	239,371	233,019	287,992	68,280	65,994	45,380
`17`	-	-	0	10,618	26,174	41,295	55,993	70,281	84,169	97,668	110,790	123,546	-	-	-
`170/4`	-	-	0	10,618	26,174	41,295	55,993	70,281	84,169	97,668	110,790	123,546	-	-	-
`42/48`	332,576	326,553	304,533	307,880	296,749	270,979	220,322	182,946	233,810	140,383	121,745	163,116	68,280	65,994	40,380
`42`	-	0	88,343	77,725	63,767	54,087	40,689	18,769	17,179	13,144	12,755	12,399	-	-	-
`43`	12,531	5,266	-	-	-	-	12,176	27	5,049	-	-	-	-	-	-
`430/8`	12,531	5,266	-	-	-	-	12,176	27	5,049	-	-	-	-	-	-
`44`	14,636	7,222	1,503	16,684	11,344	15,670	11,997	13,313	67,499	49,895	56,247	50,303	34,177	40,241	14,578
`440/4`	14,636	7,222	1,503	16,684	11,344	15,670	11,997	13,313	67,499	49,895	56,247	50,303	34,177	40,241	14,578
`45`	1,204	832	2,036	369	359	180	4,227	10,264	20,621	6,443	52,742	50,415	15,922	6,538	5,643
`450/3`	1,204	832	2,036	369	359	180	4,227	9,264	20,479	5,094	23,743	44,759	15,922	6,538	5,643
`454/9`	-	-	-	-	-	-	-	1,000	142	1,350	28,999	5,656	-	-	-
`47/48`	304,206	313,232	212,650	213,101	221,279	201,042	151,233	140,574	123,462	70,901	-	50,000	18,181	19,215	20,159
`492/3`	1,584	1,372	21,000	660	-	-	-	-	816	1,320	483	1,330	-	-	5,000
Income statement
`76A`	-	0	7,682	-	-	-	-	1,102	-	-	-	-	-	-	-
`9900`	-18,105	46,005	7,374	-2,767	4,935	-7,012	-34,366	49,605	61,283	-5,454	86,683	143,463	48,119	23,200	5,024
`62`	-	-	-	-	-	-	822	1,465	1,939	-	27,348	38,445	2,333	-	-
`630`	14,148	14,414	14,489	14,324	16,790	16,709	15,640	15,822	18,069	12,816	12,712	14,630	1,805	1,023	1,210
`631/4`	-6,957	0	-6,530	-	-	-	-	-	6,957	-	-	-	1,280	5,250	-
`640/8`	11,375	8,599	9,505	10,338	3,286	3,680	14,149	15,668	1,964	1,519	1,519	2,330	1,353	1,611	1,421
`9901`	-36,671	22,992	-10,090	-27,429	-15,140	-27,401	-64,977	16,650	32,354	-19,789	45,104	88,057	41,348	15,317	2,393
`75/76B`	10	0	17	-	3	0	-	1	1	26	168	206	90	1	-
`75`	10	0	17	-	3	0	-	1	1	26	168	206	90	1	-
`65/66B`	1,462	11,361	21,462	104	1,406	2,182	5,488	3,375	4,150	4,527	5,205	2,285	701	303	182
`65`	1,462	11,361	21,462	104	1,406	2,182	5,488	3,375	4,150	4,527	5,205	2,285	701	303	182
`9903`	-38,123	11,631	-31,535	-27,533	-16,543	-29,582	-70,465	13,276	28,205	-24,291	40,067	85,979	40,738	15,016	2,211
`67/77`	422	364	1,857	209	179	180	199	4,028	5,899	2,997	13,508	32,110	7,034	4,960	1,117
`9904`	-38,545	11,267	-33,392	-27,742	-16,722	-29,762	-70,664	9,248	22,306	-27,289	26,559	53,869	33,704	10,056	1,094
`9905`	-38,545	11,267	-33,392	-27,742	-16,722	-29,762	-70,664	9,248	22,306	-27,289	26,559	53,869	33,704	10,056	1,094
Appropriation of the result
`9906`	-196,981	-158,436	-169,703	-136,311	-108,568	-91,846	-62,084	8,580	21,638	28,132	55,421	78,862	42,993	11,095	1,094
`14P`	-158,436	-169,703	-136,311	-108,568	-	-	-	-	-	-	-	-	-	-	-
`691/2`	-	-	-	-	-	-	-	-	22,306	28,800	-	-	-	1,805	55
`6920`	-	-	-	-	-	-	-	-	-	-	-	-	-	1,805	55
`6921`	-	-	-	-	-	-	-	-	22,306	28,800	-	-	-	-	-
`694/7`	-	-	-	-	-	-	-	-	-	-	-	50,000	18,000	-	-
`694`	-	-	-	-	-	-	-	-	-	-	-	50,000	-	-	-
`695`	-	-	-	-	-	-	-	-	-	-	-	-	18,000	-	-
Social balance sheet
`9087`	-	-	-	-	-	-	-	0.1	-	-	0.6	0.6	0.1	-	-
Hours worked`1013`	-	-	-	-	-	-	-	48	-	-	1,068	1,472	212	-	-
Document	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF

Financial year	Type	Filed	Reference	Document
30-06-2025	micro format	10-02-2026	2026-00036250	PDF
30-06-2024	micro format	31-01-2025	2025-00026073	PDF
30-06-2023	micro format	05-06-2024	2024-00114444	PDF
30-06-2022	micro format	06-02-2023	2023-00025134	PDF
30-06-2021	micro format	31-01-2022	2022-03500537	PDF
30-06-2020	micro format	29-01-2021	2021-03400365	PDF
30-06-2019	micro format	31-01-2020	2020-03900527	PDF
30-06-2018	micro format	31-01-2019	2019-03500353	PDF
30-06-2017	micro format	29-01-2018	2018-03000203	PDF
30-06-2016	abbreviated format	31-01-2017	2017-03300397	PDF
30-06-2015	abbreviated format	29-01-2016	2016-03200427	PDF
30-06-2014	abbreviated format	28-01-2015	2015-03000225	PDF
30-06-2013	abbreviated format	14-02-2014	2014-04000041	PDF
30-06-2012	abbreviated format	25-01-2013	2013-01700369	PDF
30-06-2011	abbreviated format	31-01-2012	2012-02300449	PDF

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-22,523	37,406	4,399	-13,105	1,649	-10,692	-49,337	32,472	50,423	-6,973	57,816	102,688	43,153	16,340	3,603
-24,397	25,681	-18,903	-13,418	67	-13,053	-55,024	25,070	40,375	-14,472	39,271	68,499	35,508	11,078	2,304
0	0	650	2,700	1,039	21,375	1,590	8,918	115,134	36,172	16,602	203,544	2,339	5,621	1,000
-3	-6,898	-8,554	8,645	4,754	1,845	-2,076	-1,746	498	-5,731	-21,039	16,831	-8,147	15,268	-
-309,761	-285,576	-291,629	-281,797	-275,677	-259,584	-210,458	-140,357	-162,741	-73,979	-23,270	-32,738	27,431	12,261	11,804
-60.1%	-36.0%	-43.2%	-25.4%	-12.9%	-6.9%	3.3%	24.0%	18.2%	16.9%	21.5%	11.4%	32.7%	21.0%	14.1%
0.07	0.13	0.04	0.08	0.07	0.04	0.04	0.23	0.30	0.47	0.81	0.80	1.40	1.19	1.29
-	-	-	-	-	-	29.14	3.16	4.50	4.93	3.66	7.76	2.05	3.76	6.07
-	-	-	-	-	-	-745.3%	11.5%	31.5%	-56.2%	41.7%	145.2%	101.4%	57.4%	14.6%
-18.5%	4.7%	-14.7%	-10.9%	-5.8%	-10.2%	-24.7%	2.8%	5.7%	-9.5%	9.0%	16.6%	33.2%	12.0%	2.1%
-15.41	3.29	0.20	-126.31	-	-	-	-	-	-	-	-	-	-	-

Item	30-06-2025	30-06-2024	30-06-2023	30-06-2022
Tangible fixed assets	-	-	€650	€2,700
	€14,148	€14,414	€14,489	€14,324

Bioconstat

Annual accounts 2025

Balance sheet

in euro

in euro

Position in the sector

-60.1%

0.07

-18.5%

Staff

Filed annual accounts

Filings

Key figures and ratios

Investments

Insights on Bioconstat

Next steps

Annual accounts 2025

Balance sheet

Change in equityin euro

Change in cashin euro

Position in the sector

Solvency-60.1%

Current ratio0.07

Return on assets-18.5%

Staff

Staff cost per FTE

Joined and left

Filed annual accounts

Filings

Key figures and ratios

Investments

Insights on Bioconstat

Next steps

in euro

in euro

-60.1%

0.07

-18.5%